MATCHPOINT THERAPEUTICS Trademark
Trademark Overview
On Tuesday, January 11, 2022, a trademark application was filed for MATCHPOINT THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MATCHPOINT THERAPEUTICS trademark a serial number of 97977492. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, July 11, 2024. This trademark is owned by EoCys Inc.. The MATCHPOINT THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development in the field of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease; drug development and discovery services in the field of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease; scientific research in the field of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease; providing scientific research information in the field of pharmaceuticals for the treatment of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease
General Information
| Serial Number | 97977492 |
| Word Mark | MATCHPOINT THERAPEUTICS |
| Filing Date | Tuesday, January 11, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, July 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 11, 2023 |
Trademark Statements
| Pseudo Mark | MATCH POINT THERAPEUTICS |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Pharmaceutical research and development in the field of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease; drug development and discovery services in the field of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease; scientific research in the field of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease; providing scientific research information in the field of pharmaceuticals for the treatment of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, and viral disease |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 18, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, September 30, 2022 |
| First Use In Commerce Date | Friday, September 30, 2022 |
Trademark Owner History
| Party Name | EoCys Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | EoCys Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
Trademark Events
| Event Date | Event Description |
| Friday, January 14, 2022 | NEW APPLICATION ENTERED |
| Tuesday, January 18, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 19, 2022 | ASSIGNED TO EXAMINER |
| Friday, November 4, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, November 4, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, November 4, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, May 4, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, May 4, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 5, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 21, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 11, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 11, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 5, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, January 5, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, January 5, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, January 5, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, January 5, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, January 24, 2024 | DIVISIONAL REQUEST RECEIVED |
| Wednesday, January 24, 2024 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, January 24, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| Wednesday, February 7, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, February 16, 2024 | DIVISIONAL PROCESSING COMPLETE |
| Friday, February 16, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, January 24, 2024 | USE AMENDMENT FILED |
| Wednesday, March 27, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 27, 2024 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, March 27, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, July 11, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, July 11, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
